Filter By Unselect All
Sub Category Unselect
Overview (7)
Country Unselect See All
Companies Unselect See All
Selected Filter(s): Reset All
- Category Reset
- Sub Category Reset
- Country Reset
API Manufacturing >> Cytotoxic Compound >> Overview
For more than 20 years we have been able to manufacture highly potent substances, e. g. cytotoxic substances, in a contained unit.
Website
API Manufacturing >> Cytotoxic Compound >> Overview
With a huge background of more than 25 years in manufacturing injection products for worldwide markets, Pierre Fabre CDMO services is now covering all the needs of your parenteral manufacturing and development activities to be outsourced.
API Manufacturing >> Cytotoxic Compound >> Overview
Indena HPAIs contract manufacturing services include a full range of high-power manufacturing capabilities such as extraction, isolation, purification and synthetic modifications for active pharmaceutical ingredients on a wide range of scales.
API Manufacturing >> Cytotoxic Compound >> Overview
Our technical team continuously strives to develop new routes of synthesis for both general and cytotoxic APIs.
Production of Cytotoxic Compounds 
API Manufacturing >> Cytotoxic Compound >> Overview
Fermion produces cytotoxic and non-cytotoxic HPAPIs equipped with two fully automated HPAPI modules (0.1 - 1 µg/m3) with reactors of 250 L and 400 L.
API Manufacturing >> Cytotoxic Compound >> Overview
Dedicated laboratory and infrastructure addressing the needs of clients with highly potent synthetic molecules including containment solutions for beta-lactams.
Process Development And Manufacture of The Cytotoxic Drug-Linker Payload
API Manufacturing >> Cytotoxic Compound >> Overview
Company can fully support all the stages of the ADC pipeline, starting from POC studies or internalizing already existing procedures for a fast track to the GMP manufacture.